BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19179456)

  • 21. Methylation pattern of the O6-methylguanine-DNA methyltransferase gene in colon during progressive colorectal tumorigenesis.
    Nagasaka T; Goel A; Notohara K; Takahata T; Sasamoto H; Uchida T; Nishida N; Tanaka N; Boland CR; Matsubara N
    Int J Cancer; 2008 Jun; 122(11):2429-36. PubMed ID: 18240147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating ctDNA methylation quantification of two DNA methyl transferases in papillary thyroid carcinoma.
    Khatami F; Teimoori-Toolabi L; Heshmat R; Nasiri S; Saffar H; Mohammadamoli M; Aghdam MH; Larijani B; Tavangar SM
    J Cell Biochem; 2019 Oct; 120(10):17422-17437. PubMed ID: 31127647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
    Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
    World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of real-time methylation-specific PCR to determine O6-methylguanine-DNA methyltransferase gene promoter methylation in glioma.
    Vlassenbroeck I; Califice S; Diserens AC; Migliavacca E; Straub J; Di Stefano I; Moreau F; Hamou MF; Renard I; Delorenzi M; Flamion B; DiGuiseppi J; Bierau K; Hegi ME
    J Mol Diagn; 2008 Jul; 10(4):332-7. PubMed ID: 18556773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of DNA degradation in formalin-fixed, paraffin-embedded (FFPE) tissue on locus-specific methylation assessment by MS-HRM.
    Daugaard I; Kjeldsen TE; Hager H; Hansen LL; Wojdacz TK
    Exp Mol Pathol; 2015 Dec; 99(3):632-40. PubMed ID: 26551081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A methylation-specific and SYBR-green-based quantitative polymerase chain reaction technique for O6-methylguanine DNA methyltransferase promoter methylation analysis.
    Hattermann K; Mehdorn HM; Mentlein R; Schultka S; Held-Feindt J
    Anal Biochem; 2008 Jun; 377(1):62-71. PubMed ID: 18384736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased expression of the histone H3 lysine 4 methyltransferase MLL4 and the histone H3 lysine 27 demethylase UTX prolonging the overall survival of patients with glioblastoma and a methylated MGMT promoter.
    Kim J; Lee SH; Jang JH; Kim MS; Lee EH; Kim YZ
    J Neurosurg; 2017 May; 126(5):1461-1471. PubMed ID: 27367247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of methylation-sensitive high-resolution melting (MS-HRM) for the detection of stool DNA methylation in colorectal neoplasms.
    Xiao Z; Li B; Wang G; Zhu W; Wang Z; Lin J; Xu A; Wang X
    Clin Chim Acta; 2014 Apr; 431():154-63. PubMed ID: 24518356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. O(6) -methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy with concomitant and adjuvant temozolomide.
    Lechapt-Zalcman E; Levallet G; Dugué AE; Vital A; Diebold MD; Menei P; Colin P; Peruzzy P; Emery E; Bernaudin M; Chapon F; Guillamo JS
    Cancer; 2012 Sep; 118(18):4545-54. PubMed ID: 22359215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MGMT promoter methylation and glioblastoma: a comparison of analytical methods and of tumor specimens.
    Lattanzio L; Borgognone M; Mocellini C; Giordano F; Favata E; Fasano G; Vivenza D; Monteverde M; Tonissi F; Ghiglia A; Fillini C; Bernucci C; Merlano M; Lo Nigro C
    Int J Biol Markers; 2015 May; 30(2):e208-16. PubMed ID: 25588856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA methylation analysis with methylation-sensitive high-resolution melting (MS-HRM) reveals gene panel for glioma characteristics.
    Majchrzak-Celińska A; Dybska E; Barciszewska AM
    CNS Neurosci Ther; 2020 Dec; 26(12):1303-1314. PubMed ID: 32783304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency of O⁶-methylguanine-DNA methyltransferase promoter methylation in cytological samples from small cell lung cancer.
    Miglio U; Mezzapelle R; Paganotti A; Veggiani C; Mercalli F; Mancuso G; Gaudino E; Rena O; Buosi R; Boldorini R
    Diagn Cytopathol; 2015 Nov; 43(11):947-52. PubMed ID: 26152836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylation-Sensitive High Resolution Melting (MS-HRM).
    Hussmann D; Hansen LL
    Methods Mol Biol; 2018; 1708():551-571. PubMed ID: 29224163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PTCH promoter methylation at low level in sporadic basal cell carcinoma analysed by three different approaches.
    Heitzer E; Bambach I; Dandachi N; Horn M; Wolf P
    Exp Dermatol; 2010 Oct; 19(10):926-8. PubMed ID: 20849535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bisulfite-Based DNA Methylation Analysis from Recent and Archived Formalin-Fixed, Paraffin Embedded Colorectal Tissue Samples.
    Kalmár A; Péterfia B; Hollósi P; Wichmann B; Bodor A; Patai ÁV; Schöller A; Krenács T; Tulassay Z; Molnár B
    Pathol Oncol Res; 2015 Sep; 21(4):1149-56. PubMed ID: 25991403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [GSTP1, APC and RASSF1 gene methylation in prostate cancer samples: comparative analysis of MS-HRM method and Infinium HumanMethylation450 BeadChip beadchiparray diagnostic value].
    Skorodumova LO; Babalyan KA; Sultanov R; Vasiliev AO; Govorov AV; Pushkar DY; Prilepskaya EA; Danilenko SA; Generozov EV; Larin AK; Kostryukova ES; Sharova EI
    Biomed Khim; 2016 Nov; 62(6):708-714. PubMed ID: 28026816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of MGMT promoter methylation in glioblastoma using pyrosequencing.
    Xie H; Tubbs R; Yang B
    Int J Clin Exp Pathol; 2015; 8(1):636-42. PubMed ID: 25755756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome.
    Draht MX; Smits KM; Jooste V; Tournier B; Vervoort M; Ramaekers C; Chapusot C; Weijenberg MP; van Engeland M; Melotte V
    Clin Epigenetics; 2016; 8():44. PubMed ID: 27118999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, MethyLight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of 100 glioblastoma patients.
    Quillien V; Lavenu A; Karayan-Tapon L; Carpentier C; Labussière M; Lesimple T; Chinot O; Wager M; Honnorat J; Saikali S; Fina F; Sanson M; Figarella-Branger D
    Cancer; 2012 Sep; 118(17):4201-11. PubMed ID: 22294349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular analysis of APC promoter methylation and protein expression in colorectal cancer metastasis.
    Chen J; Röcken C; Lofton-Day C; Schulz HU; Müller O; Kutzner N; Malfertheiner P; Ebert MP
    Carcinogenesis; 2005 Jan; 26(1):37-43. PubMed ID: 15375009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.